Omar Alhalabi, MD

Omar Alhalabi, MD, University of Texas MD Anderson Cancer Center

Articles by Omar Alhalabi, MD
UNITE Study: Outcomes With SG for Patients with Variant Histologies
Vadim Koshkin, MDUrothelial Carcinoma | February 12, 2024
The outcomes related to sacituzumab govitecan for patients with variant histologies are highlighted.
View More
UNITE Study: Sequencing Erdafitinib and EV for Patients With FGFR2/3-Altered Disease
Vadim Koshkin, MDAdvanced Urothelial Carcinoma | May 20, 2024
The potential for sequencing erdafitinib and EV for patients with FGFR2/3-altered disease is considered.
View More
UNITE Study: Impact of Squamous, Other Histologies on Outcomes With EV
Vadim Koshkin, MDAdvanced Urothelial Carcinoma | May 20, 2024
The impact of squamous and other histologies on outcomes with EV are dissected.
View More
UNITE Study: Design, Patients Sampled, and Outcomes With EV After Switch Maintenance Avelumab
Vadim Koshkin, MDAdvanced Urothelial Carcinoma | May 20, 2024
The design of UNITE, patients sampled, and outcomes with EV after switch maintenance avelumab are explored.
View More

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    About Us

    Contributors and Partners

    Editorial Policy

    Advertising

    Connect

    eNewsletters

    Calendar

    Contact Us

    Contribute

    Our Network

    MashupMD

    Cancer Nursing Today

    Urban Health Today

    Blood Cancers Today

    DocWire News

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |